Anil Bioplus to foray into nutraceutical segment

Ahmedabad-based Anil Bioplus (ABL), promoted by the Anil Group, today said it has invested Rs 150 crore to set up a greenfield plant at Halol in Gujarat that will help the company to foray into the nutraceutical segment.
"As of now, we already provide a range of products for end-user industries like food and beverage, textiles, pharmaceuticals, paper and now with Gluconates we will enter into the nutraceutical industry.
"We believe that value added segment in the food processing industry offers maximum growth. We will enter the nutraceutical segment to harness this potential," Anil Bioplus' Executive Director, Darshan Mehta, said in a release issued here.

The company, which is among the earliest to introduce Gluconates through fermentation process in the country, has invested around Rs 150 crore in a greenfield plant at Halol.
"The capacity of this greenfield plant, which is expandable and has infrastructure that is USFDA approved, will also manufacture enzymes and citrates," Mehta added.
ABL expects the new facility to be operational by next financial year and will focus on fulfilling both domestic and global market demand.
The company is engaged in manufacturing and marketing of bio-chemicals enzymes and microbes, which cater to the needs and requirements of diversified industrial segments.
The Anil Group's activities span across corn wet milling, biotechnology (industrial enzymes and gluconates), food and agro businesses, infrastructure development, knowledge solutions and garment export.